Due to the focused cellular binding in the cortical GM by these AGS+ rhAbs from MS patients, we hypothesized that the AGS+ rhAbs were binding to either neurons or astrocytes in the cortex. This evidence concerns the gene JAG1 and myeloid sarcoma.